Biased Ligands. Better Drugs.

Press Releases

Recent News

July 20, 2017 Trevena To Host 2017 Analyst Day and Announce Results of ATHENA Open Label Safety Study of OLINVO

July 12, 2017 Trevena to Host Analyst Day on July 20, 2017

June 20, 2017 Trevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain Medications

June 2, 2017 Trevena to Present at Investor Conferences in June

May 31, 2017 Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

May 22, 2017 Trevena Announces Presentations During the 36th Annual Scientific Meeting of the American Pain Society

May 4, 2017 Trevena Reports First Quarter 2017 Financial Results and Provides Corporate Update

April 26, 2017 Trevena to Present at the Deutsche Bank Securities 42nd Annual Healthcare Conference

April 6, 2017 Trevena Announces Presentations at the 42nd Annual Regional Anesthesiology and Acute Pain Medicine Meeting

March 29, 2017 Trevena to Present at Needham & Company’s 16th Annual Healthcare Conference

March 14, 2017 Trevena to Present at the Oppenheimer 27th Annual Healthcare Conference

March 14, 2017 Inclement Weather Results in Cancellation of Trevena Presentation at the 2017 Barclays Global Healthcare Conference

March 10, 2017 Trevena to Present at the 2017 Barclays Global Healthcare Conference

March 8, 2017 Trevena Reports Full Year 2016 Earnings

March 2, 2017 Trevena to Host Conference Call on March 8th to Discuss Full Year 2016 Financial Results

February 21, 2017 Trevena Announces Positive Top-line Results from Two Phase 3 Pivotal Efficacy Studies of Intravenous Oliceridine in Moderate-to-Severe Acute Pain

January 4, 2017 Trevena Completes Enrollment of Phase 3 APOLLO Pivotal Efficacy Trials of Oliceridine for Moderate-to-Severe Acute Pain

Copyright © Trevena, Inc.